{"name":"Graegis Pharmaceuticals Ltd","slug":"graegis-pharmaceuticals-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"GR1014-CG 2.4%","genericName":"GR1014-CG 2.4%","slug":"gr1014-cg-2-4","indication":"Other","status":"phase_2"},{"name":"GR1014-CG 4.7%","genericName":"GR1014-CG 4.7%","slug":"gr1014-cg-4-7","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"GR1014-CG 2.4%","genericName":"GR1014-CG 2.4%","slug":"gr1014-cg-2-4","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GR1014-CG 4.7%","genericName":"GR1014-CG 4.7%","slug":"gr1014-cg-4-7","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQXM2TzRGdVo4MWQ1RjMxNENFM1VZam1GNEtONTVGMmN1bFpGaFFJUElqc0doQTNPRnVsMmpXd0ZPTGJZUURBQWt3NWk4OWJUYUpDVDBmc2VWTFlrbEVWZGZHSkVPSlZmdXpValdTdWVDVDFUemVtcFZWT1F5blJBaENWa3BMUUtzcThUOW9nOUNpSWk1UWtfcktGSVRqVUxOeUp0S2xCM3o0dlFwOVJXUWJSYVM?oc=5","date":"2024-02-19","type":"pipeline","source":"PMLiVE","summary":"Medicxi forms Alys Pharma with six dermatology-focused companies with $100m - PMLiVE","headline":"Medicxi forms Alys Pharma with six dermatology-focused companies with $100m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOWHlRYV90N2txWkNnb21kc3ZUZVZUTFJxSVI0UUcwdnZoVlk0ZWNZN2hjYzZhRGtFeTRnWEtGOFFtUUhreEZfMXFuajIxWENHelhNckFYeWhCaG1kZEJYdEg2YlVXMU5aLWthRVF6ZG91OXM5emJMQng1X09sbU1KZ1k2Uk16cmZlZm1rejhwOTJ1aUlnb2hmMVlB?oc=5","date":"2024-02-19","type":"pipeline","source":"Greater Geneva Bern area","summary":"Alys Pharmaceuticals launches in Geneva with USD 100 million investment - Greater Geneva Bern area","headline":"Alys Pharmaceuticals launches in Geneva with USD 100 million investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTFB1RU1mQTgwc2laSEdHR2xDMDB5bFYwaEd6NUlQc3daNW9DbkVLVE0zLWNkLTNvYzlWUEViZ1EybUNNdllnZy1yLTIyemxxV2NVTWhnV2xxVm5DbTjSAWNBVV95cUxOOVFWaWdzaXNkTmU0SHkxWWx5VHZNVU02NWllMFB3alp1WlpsRHlBY19hczRwUUFOeFFPRl9Rd212RlAwNFpZd29XUFV6X2tEOGxVUk5yQXlybUJiVlhXck1GZEU?oc=5","date":"2024-02-14","type":"pipeline","source":"Freethink","summary":"New pharma supergroup aims to tackle skin disorders - Freethink","headline":"New pharma supergroup aims to tackle skin disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxORTFCS0pwZEU0OGhaZWZ0bDN1NDNDX2J1cldBMUFiRjgwUUR6T1FJUXdvcVhiY212MlBpX0VEa3dyNVkwUDNfSl95NnZVc2JvUlZZSWZzSURHWUtpVDdDY1NITGp1LTJqb3BJTFRQYTlhV2xmeHp6RDVjM1AyM1ltczkwWkYtZnVNR3Nmb2pDLVUweDhCUVdMTzEzenlwVFJ6NHBEUDN5RHdtNlZsWnBpbDhGYl82OTYtZUZZ?oc=5","date":"2024-02-13","type":"pipeline","source":"Contract Pharma","summary":"Introducing Alys Pharmaceuticals: A New Immuno-Dermatology Focused Company - Contract Pharma","headline":"Introducing Alys Pharmaceuticals: A New Immuno-Dermatology Focused Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcnNxSUpNV1NyZjVDNWdueEZSOWQtTDBSMGZ2OC1zcm9zLXc1MUpNN29MOHluOVd3YXpFZC1pckdhRWpWYnNqRmY5QUN5Y3hub0JGS0VfMC03OTExRXUyeW0tbzZaN19KZEFjcE1yOXpMLW9zalhCdVRtRW52a1pISEktS01FdEEtbVRqUmVB?oc=5","date":"2024-02-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Alys Pharmaceuticals announces launch with funding of $100m - Pharmaceutical Technology","headline":"Alys Pharmaceuticals announces launch with funding of $100m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQR3dwSHhkLUNXbGFJZHpURk5FSmF0eENySUN3blVna2dNYm5TQ00wMGVId2RyRWg2cllGb19ScTJNSXNtQmNxX2JhZk14V2dtX2lhcEVmQmdwSnlheEloQnBQRlFTYlc4UHNfWjlFWkhxOW42RDJLX29GeGtMa3pVNkZLZ1hJTkxCREpjSGYyU3ZXT0JJbHg5T0ZSRVNGNkZWM28wUA?oc=5","date":"2024-02-12","type":"pipeline","source":"BioSpace","summary":"Medicxi Combines Six Portfolio Companies with $100M to Launch Alys Pharma - BioSpace","headline":"Medicxi Combines Six Portfolio Companies with $100M to Launch Alys Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPUVBQZGVpTzIwZ2FkelVGY3JXWHNPWDNZQTc5ZGppdVlxYkdLb2xEYnFrZWFFVWlKdjFydFNTcm9KS2w0ODhzNkZIUm9DYVNUbDBwMG9MTW53RkxVblFVdVhzSHNramlDVENTS3YwczlKUGhPMWVIeHB3QTd3MjI2b3VSUThJbGRJZlhrb0djX1MxYTNoanh3VmtSODY?oc=5","date":"2024-02-12","type":"pipeline","source":"BioPharma Dive","summary":"Alys launches with $100M and a pipeline of skin disease drugs - BioPharma Dive","headline":"Alys launches with $100M and a pipeline of skin disease drugs","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}